# Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunotherapy-of-ipilimumab-and-nivolumab-in-patients-with-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Oliver Klein,Damien Kee,Ben Markman,Michael Michael,Craig Underhill,Matteo S. Carlino,Louise Jackett,Caroline Lum,Clare L. Scott,Adnan Nagrial,Andreas Behren,Jane Y. So,Jodie Palmer,Jonathan Cebon |
| Citations | 172 |
| DOI | 10.1158/1078-0432.ccr-20-0621 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/clincancerres/article-pdf/26/17/4454/2061053/4454.pdf |
| OpenAlex ID | https://openalex.org/W3035208766 |
| PMID | 32532787 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Michael Michael](https://scholariq.org/researchers/michael-michael/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Thyroid Cancer Diagnosis and Treatment](https://scholariq.org/topics/thyroid-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.